These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32158694)

  • 1. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
    Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
    Front Oncol; 2020; 10():215. PubMed ID: 32158694
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer.
    Kong X; Hu S; Yuan Y; Du Y; Zhu Z; Song Z; Lu S; Zhao C; Yan D
    J Cancer; 2020; 11(11):3357-3368. PubMed ID: 32231742
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of lncRNA-miRNA-mRNA Networks Linked to Non-small Lung Cancer Resistance to Inhibitors of Epidermal Growth Factor Receptor.
    Wang T; Yang C; Li B; Xing Y; Huang J; Zhang Y; Bu S; Ge H
    Front Genet; 2021; 12():758591. PubMed ID: 34868237
    [No Abstract]   [Full Text] [Related]  

  • 4. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis.
    Wang P; Chen D; Ma H; Li Y
    Onco Targets Ther; 2017; 10():5137-5149. PubMed ID: 29123412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-mediated ceRNA network was identified as a crucial determinant of differential effects in periodontitis and periimplantitis by high-throughput sequencing.
    Zhou H; Chen D; Xie G; Li J; Tang J; Tang L
    Clin Implant Dent Relat Res; 2020 Jun; 22(3):424-450. PubMed ID: 32319195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
    Shi SL; Zhang ZH
    Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure.
    Zheng Y; Zhang Y; Zhang X; Dang Y; Cheng Y; Hua W; Teng M; Wang S; Lu X
    Front Cardiovasc Med; 2021; 8():747449. PubMed ID: 34692796
    [No Abstract]   [Full Text] [Related]  

  • 10. Knockdown of Long Non-Coding RNA
    Zhan Y; Abuduwaili K; Wang X; Shen Y; Nuerlan S; Liu C
    Cancer Manag Res; 2020; 12():7725-7737. PubMed ID: 32943921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing long intergenic non-coding RNA 00707 enhances cisplatin sensitivity in cisplatin-resistant non-small-cell lung cancer cells by sponging miR-145.
    Zhang H; Luo Y; Xu W; Li K; Liao C
    Oncol Lett; 2019 Dec; 18(6):6261-6268. PubMed ID: 31788103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
    Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway.
    Chen R; Xin G; Zhang X
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1327-1339. PubMed ID: 31622249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
    Yu S; Qin X; Chen T; Zhou L; Xu X; Feng J
    Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells
    Zhang S; Wang Q; Li W; Chen J
    Front Mol Biosci; 2021; 8():793493. PubMed ID: 35127818
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
    Li S; Liu X; Li H; Pan H; Acharya A; Deng Y; Yu Y; Haak R; Schmidt J; Schmalz G; Ziebolz D
    J Periodontal Res; 2018 Aug; 53(4):495-505. PubMed ID: 29516510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.